Verónica Noya

Verónica Noya

Auto-generated profile, based on publicly available information

Verónica Noya

Laboratory of Molecular Biology, Sanatorio Americano, 11600 Montevideo, Uruguay

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2022 in Science Advances
Verified
Journal Article
Open access
MVMaite Duhalde Vega
Maite Duhalde Vega
DODaniela Olivera
Daniela Olivera
GDGustavo Gastão Davanzo
Gustavo Gastão Davanzo
MBMauricio Bertullo
Mauricio Bertullo
VNVerónica Noya
Verónica Noya
MHMarcelo Hill
Marcelo Hill
Severe COVID-19 is associated with hyperinflammation and weak T cell responses against SARS-CoV-2. However, the links between those processes remain partially characterized. Moreover, whether and how therapeutically manipulating T cells may benefit patients are unknown. Our genetic and pharmacological evidence demonstrates that the ion channel TMEM176B inhibited inflammasome activation triggered by SARS-CoV-2 and SARS-CoV-2–related murine β-coronavirus. Tmem176b −/− mice infected with murine β-coronavirus developed inflammasome-dependent T cell dysfunction and critical disease, which was controlled by modulating dysfunctional T cells with PD-1 blockers. In critical COVID-19, inflammasome activation correlated with dysfunctional T cells and low monocytic TMEM176B expression, whereas PD-L1 blockade rescued T cell functionality. Here, we mechanistically link T cell dysfunction and inflammation, supporting a cancer immunotherapy to reinforce T cell immunity in critical β-coronavirus disease.